SCHEMBL24928651

SCHEMBL24928651

Cc1oncc1-c1cc(NS(=O)(=O)c2cc(C(=O)O)ccc2C2CC2)c(OC2CCCC2)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BRD4 O60885 1/20 0.36
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RAD52 P43351 1/20 0.35
FABP4 P15090 1/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
CHEK1 O14757 1/20 0.35
RPS6KA3 P51812 1/20 0.35
SRPK1 Q96SB4 1/20 0.35
PTGDR Q13258 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
PTK2B Q14289 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31198500 1.00 ACLY (0.38) ACLYL3MBTL1BRD4POLBHSD17B10
SCHEMBL30153324 0.98 ACLY (0.38) ACLYL3MBTL1BRD4POLBHSD17B10
SCHEMBL24928843 0.98 ACLY (0.38) ACLYL3MBTL1BRD4POLBHSD17B10
SCHEMBL30845553 0.92 ACLY (0.40) ACLYL3MBTL1PDE4APDE4BPDE4C
SCHEMBL30153260 0.92 ACLY (0.40) ACLYL3MBTL1PDE4APDE4BPDE4C
SCHEMBL24928850 0.91 ACLY (0.36) ACLYL3MBTL1POLBHSD17B10RAD52
SCHEMBL30153306 0.91 ACLY (0.36) ACLYL3MBTL1POLBHSD17B10RAD52
SCHEMBL24928655 0.91 ACLY (0.41) ACLYBRD4RAD52FABP4PTK2B
SCHEMBL31198427 0.91 ACLY (0.41) ACLYBRD4RAD52FABP4PTK2B
SCHEMBL24928647 0.87 BRD4 (0.44) ACLYBRD4POLBRAD52PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007188-A1 PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS Grey Wolf Therapeutics Limited (GB) 2023-02-02 WO disclosed